Biography of Blandine Lacroix

Last update: 5 days ago

Career

Blandine was Product Manager at Eli Lilly APAC, and Marketing Associate, Graduate Programme at Avery Dennison. Blandine Lacroix joined Novo Nordisk in 2002. Blandine served as Title Vice President, Diabetes Marketing and Vice President, Obesity Marketing for Novo Nordisk.

Blandine Lacroix is currently Corporate Vice President, Strategy and Rare Disease at Novo Nordisk USA - View - Novo Nordisk USA org chart

Create your alert
to follow the career of Blandine Lacroix.

Education

Blandine Lacroix has a Master of Business Administration in International Business from INSEEC Business School in 1992 and a Master in International Business Studies in International Marketing and International Business from University of South Carolina - The Moore School of Business in 1995.

They have also studied at INSEEC Business School :

Find more alumni from INSEEC Business School


They have also studied at University of South Carolina - The Moore School of Business :

Find more alumni from University of South Carolina - The Moore School of Business

The colleagues of Blandine Lacroix

Company Colleagues
Industry Colleagues
  • In the Pharmaceuticals industry, Blandine Lacroix has 19,356 colleagues in 1,866 companies located in 69 countries. 8,433 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.

Report an error
Update the org chart details of Blandine Lacroix.

Get in Touch

Use our Premium/VIP Service to contact Blandine Lacroix by email now. Here are a few tips for establishing great contacts.

Send an email
to Blandine Lacroix.
With Skype, Call Novo Nordisk USA at +1 609... and ask for Blandine Lacroix.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.